bioRxivBiochemistry
Stabilization of the SARS-CoV-2 Receptor Binding Domain by Protein Core Redesign and Deep Mutational Scanning
A. C. Leonard, J. Weinstein, P. J. Steiner, A. Erbse, S. J. Fleishman, T. A. Whitehead
Abstract
Stabilizing antigenic proteins as vaccine immunogens or diagnostic reagents is a stringent case of protein engineering and design as the exterior surface must maintain recognition by receptor(s) and antigen--specific antibodies at multiple distinct epitopes. This is a challenge, as stability-enhancing mutations must be focused on the protein core, whereas successful computational stabilization algorithms typically select mutations at solvent-facing positions. In this study we report the stabilization of SARS-CoV-2 Wuhan Hu-1 Spike receptor binding domain (S RBD) using a combination of deep mutational scanning and computational design, including the FuncLib algorithm. Our most successful design encodes I358F, Y365W, T430I, and I513L RBD mutations, maintains recognition by the receptor ACE2 and a panel of different anti-RBD monoclonal antibodies, is between 1-2{degrees}C more thermally stable than the original RBD using a thermal shift assay, and is less proteolytically sensitive to chymotrypsin and thermolysin than the original RBD. Our approach could be applied to the computational stabilization of a wide range of proteins without requiring detailed knowledge of active sites or binding epitopes, particularly powerful for cases when there are multiple or unknown binding sites.
- assay: protein structure
- research focus: protein folding & dynamics
- research focus: protein design
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design
D. Ellis, N. Brunette, … N. P. King·bioRxiv·May 15, 2021
- Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response
Thayne H. Dickey, Wai Kwan Tang, … Niraj Harish Tolia·Science AdvancesPeer-reviewed·Sep 14, 2022
- Systemic Effects of Missense Mutations on SARS-CoV-2 Spike Glycoprotein Stability and Receptor Binding Affinity
Shaolei Teng, Adebiyi Sobitan, … Qiyi Tang·Briefings in BioinformaticsPeer-reviewed·Aug 26, 2020
- Structural and Computational Design of a SARS-CoV-2 Spike Antigen with Increased Receptor Binding Domain Exposure and Improved Immunogenicity
J. Williams, M. Biancucci, … W. Harshbarger·bioRxiv·Nov 29, 2022
- De novo design of high-affinity antibody variable regions (Fv) against the SARS-CoV-2 spike protein
V. S. Boorla, R. Chowdhury, C. D. Maranas·bioRxiv·Apr 9, 2020
- COVID-19 dominant D614G mutation in the SARS-CoV-2 spike protein desensitizes its temperature-dependent denaturation
T.-J. Yang, P.-Y. Yu, … S.-T. D. Hsu·bioRxiv·Mar 28, 2021